In Western Europe, the median value of enterprise value to earnings before interest, tax, depreciation and amortization (EV/EBITDA) in the health & pharmaceuticals sector as of 2024, was a multiple of approximately 15.3x. Heathcare information and technology companies saw the highest EV/EBITDA multiple with 18.9x in 2024.
Average EV/EBITDA multiples in the health & pharmaceuticals sector in Western Europe from 2019 to 2024, by industry
Western Europe. Values are as of January each year. A total of 715 companies were included in the calculation for 2024. Figures for years 2019 to 2023 were previously published by the source. Figure for Drugs (Biotechnology) was not given in 2022.
Enterprise value = Market value of equity + Market value of debt - Cash. EBITDA = Estimated by adding depreciation and amortization back to operating income (EBIT). Only positive EBITDA companies.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Leonard N. Stern School of Business. (January 5, 2024). Average EV/EBITDA multiples in the health & pharmaceuticals sector in Western Europe from 2019 to 2024, by industry [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/1028021/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-europe/
Leonard N. Stern School of Business. "Average EV/EBITDA multiples in the health & pharmaceuticals sector in Western Europe from 2019 to 2024, by industry." Chart. January 5, 2024. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/1028021/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-europe/
Leonard N. Stern School of Business. (2024). Average EV/EBITDA multiples in the health & pharmaceuticals sector in Western Europe from 2019 to 2024, by industry. Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/1028021/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-europe/
Leonard N. Stern School of Business. "Average Ev/Ebitda Multiples in The Health & Pharmaceuticals Sector in Western Europe from 2019 to 2024, by Industry." Statista, Statista Inc., 5 Jan 2024, https://www.statista.com/statistics/1028021/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-europe/
Leonard N. Stern School of Business, Average EV/EBITDA multiples in the health & pharmaceuticals sector in Western Europe from 2019 to 2024, by industry Statista, https://www.statista.com/statistics/1028021/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-europe/ (last visited December 22, 2024)
Average EV/EBITDA multiples in the health & pharmaceuticals sector in Western Europe from 2019 to 2024, by industry [Graph], Leonard N. Stern School of Business, January 5, 2024. [Online]. Available: https://www.statista.com/statistics/1028021/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-europe/
